<Suppliers Price>

CuATSM

Names

[ CAS No. ]:
68341-09-3

[ Name ]:
CuATSM

[Synonym ]:
Copper(2+) (2E,2'E)-2,2'-[(2E,3E)-2,3-butanediylidene]bis(N-methylhydrazinecarbimidothioate)
Hydrazinecarbothioamide, 2,2'-[(1E,2E)-1,2-dimethyl-1,2-ethanediylidene]bis[N-methyl-, copper(2+) salt, (2E,2'E)- (1:1)
ATSM CU-64
0YDK1H9L3A
Cu-ASTM

Biological Activity

[Description]:

CuATSM is a highly potent radical-trapping antioxidant (RTA) and inhibitor of (phospho)lipid peroxidation, thereby accounting for its (their) ability to inhibit ferroptosis.

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Ferroptosis
Research Areas >> Neurological Disease

[References]

[1]. Zilka O, et al. Radical-Trapping Antioxidant Activity of Copper and Nickel Bis(Thiosemicarbazone) Complexes Underlies Their Potency as Inhibitors of Ferroptotic Cell Death. J Am Chem Soc. 2021 Nov 17;143(45):19043-19057.

Chemical & Physical Properties

[ Molecular Formula ]:
C8H14CuN6S2

[ Molecular Weight ]:
321.91

[ Exact Mass ]:
321.001740

[ Appearance of Characters ]:
powder

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
DMSO: soluble10mg/mL, clear

Safety Information

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.

Neurobiol. Dis. 81 , 20-4, (2015)

Mutations in the metalloprotein Cu,Zn-superoxide dismutase (SOD1) cause approximately 20% of familial cases of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease for which effectiv...

Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis.

J. Neurosci. 34(23) , 8021-31, (2014)

Mutations in the metallo-protein Cu/Zn-superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS) in humans and an expression level-dependent phenotype in transgenic rodents. We show that o...

Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.

Amyotroph. Lateral Scler. Frontotemporal Degener. 14(7-8) , 586-90, (2013)

Our objective was to assess the copper(II) complex of diacetylbis(4-methylthiosemicarbazone) [Cu(II)(atsm)] for its preclinical potential as a novel therapeutic for ALS. Experimental paradigms used we...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.